Document:

jnp-ex1032_761.htm

 

Exhibit 10.32

 

AMENDMENT NO. 2 TO
LICENSE AGREEMENT

THIS AMENDMENT NO. 2 TO LICENSE AGREEMENT (this “Amendment”) is entered into as of November 10, 2016 (the “Amendment No. 2 Effective Date”) by and among Juniper Pharmaceuticals, Inc., as successor to Columbia Laboratories, Inc., a Delaware corporation (“Juniper”), Columbia Laboratories (Bermuda) Ltd., a Bermuda corporation (“Columbia”), and Allergan Sales, LLC, as assignee of Coventry Acquisition, LLC, a Delaware limited liability company (“Allergan”).  Juniper, Columbia and Allergan are hereinafter sometimes referred to each as a “Party” and collectively as the “Parties.”

WHEREAS, Juniper, Columbia and Allergan are parties to that certain License Agreement, dated as of March 3, 2010, as amended and supplemented by that certain Side Letter, dated November 11, 2013 (the “License Agreement”); and

WHEREAS, the Parties wish to amend the License Agreement on the terms set forth herein.

NOW, THEREFORE, in consideration of the premises and mutual covenants herein contained and for other good and valuable consideration (the receipt and sufficiency of which is hereby acknowledged), the Parties hereby agree as follows:

	
1.
	
DEFINITIONS

Capitalized terms used in this Amendment which are not defined herein shall have the meanings ascribed to them in the License Agreement.

	
2.
	
AMENDMENTS

	
 
	
2.1
	
Amendment to Section 2.1(a).  Section 2.1(a) is hereby amended by deleting “(except as provided in the PC A)”.

	
 
	
2.2
	
Deletion of Section 2.1(b)(ii).  Section 2.l(b)(ii) is hereby deleted and replaced with “Omitted”.

	
 
	
2.3
	
Amendment to Section 3.4(a)(vi).  The last sentence of Section 3.4(a)(vi) is hereby amended in its entirety to read as follows:

“Any remainder will be retained by the Party prosecuting the Product Infringement action or proceeding.”

	
3.
	
REPRESENTATIONS AND WARRANTIES

	
 
	
3.1
	
Each Party represents and warrants to the other Party, as of the Amendment No. 2 Effective Date, that:

 

 

	
 
	
(a)
	
such Party has the power and authority and the legal right to enter into this Amendment and perform its obligations under the License Agreement as amended hereunder;

	
 
	
(b)
	
such Party has taken all necessary action on its part required to authorize the execution and delivery of this Amendment and the performance of its obligations under the License Agreement as amended hereunder;

	
 
	
(c)
	
entering into this Amendment is not in conflict with any other agreement to which such Party is a party to; and

	
 
	
(d)
	
this Amendment has been duly executed and delivered on behalf of such Party and constitutes a legal, valid and binding obligation of such Party and is enforceable against it in accordance with its terms subject to the effects of bankruptcy, insolvency or other laws of general application affecting the enforcement of creditor rights and judicial principles affecting the availability of specific performance and general principles of equity, whether enforceability is considered a proceeding at law or equity.

	
4.
	
LICENSE AGREEMENT

Except as explicitly modified by the terms of this Amendment, the other provisions of the License Agreement shall remain in full force and effect.  The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of a Party under the License Agreement.  Unless otherwise indicated, the terms “Article,” “Section,” “Exhibit” or “clause” refer to the specified Article.  Section, Exhibit or clause of the License Agreement.

	
5.
	
GOVERNING LAW

This Amendment (including any claim or controversy arising out of or relating to this Amendment) shall be governed by and construed in accordance with the Laws of the State of Delaware without regard to conflict of law principles that would result in the application of any Law other than the Laws of the State of Delaware.

	
6.
	
COUNTERPARTS

This Amendment may be signed in counterparts, each and every one of which shall be deemed an original, notwithstanding variations in format or file designation which may result from the electronic transmission, storage and printing of copies of this Amendment from separate computers or printers.  Executed signatures pages 10 this Amendment may be delivered by facsimile or a portable document format (PDF) copy (including copy(ies) sent by e-mail) and all such shall be deemed as if actual signature pages had been delivered.

[SIGNATURE PAGE FOLLOWS]

 

2

 

IN WITNESS WHEREOF, the Parties have caused this Amendment to be executed as of the date first written above.

		
	
Juniper Pharmaceuticals, Inc.

 

 

By: /s/ Alicia Secor

 

Name: Alicia Secor

 

Title: CEO

 

 
	
Allergan Sales, LLC

 

 

By: /s/ Robert Bailey

 

Name: Robert Bailey

 

Title: Chief Legal Officer

	
Columbia Laboratories (Bermuda) Ltd.

 

 

By: /s/ George O. Elston

 

Name: George O. Elston

 

Title: DirectorExhibit

Exhibit 4.1
HINES REAL ESTATE INVESTMENT TRUST, INC.
ARTICLES OF DISSOLUTION
Hines Real Estate Investment Trust, Inc., a Maryland corporation (hereinafter called the “Corporation”), hereby certifies to the State Department of Assessments and Taxation of Maryland that:

FIRST:  The name of the Corporation is as set forth above, and the address of the principal office of the Corporation in the State of Maryland is c/o The Corporation Trust Incorporated, 351 West Camden Street, Baltimore, Maryland 21201.

SECOND:  The name and address of the resident agent of the Corporation in the State of Maryland, who shall serve for one year after dissolution and thereafter until the affairs of the Corporation are wound up, are:  The Corporation Trust Incorporated, 351 West Camden Street, Baltimore, Maryland 21201.

THIRD:  The name and address of each director of the Corporation are as follows:

        
	
			
	Name
	 
	Address

	Jeffrey C. Hines
	 
	c/o Hines Real Estate Investment Trust, Inc.

	 
	 
	2800 Post Oak Boulevard, Suite 5000

	 
	 
	Houston, Texas 77056-6118

	 
	 
	 

	Charles M. Baughn
	 
	c/o Hines Real Estate Investment Trust, Inc.

	 
	 
	2800 Post Oak Boulevard, Suite 5000

	 
	 
	Houston, Texas 77056-6118

	 
	 
	 

	Lee A. Lahourcade
	 
	c/o Hines Real Estate Investment Trust, Inc.

	 
	 
	2800 Post Oak Boulevard, Suite 5000

	 
	 
	Houston, Texas 77056-6118

	 
	 
	 

	Stanley D. Levy
	 
	c/o Hines Real Estate Investment Trust, Inc.

	 
	 
	2800 Post Oak Boulevard, Suite 5000

	 
	 
	Houston, Texas 77056-6118

	 
	 
	 

	Paul B. Murphy Jr.
	 
	c/o Hines Real Estate Investment Trust, Inc.

	 
	 
	2800 Post Oak Boulevard, Suite 5000

	 
	 
	Houston, Texas 77056-6118

1

FOURTH:  The name, title and address of each officer of the Corporation are as follows:
	
					
	Name
	 
	Title
	 
	Address

	Sherri W. Schugart
	 
	President and Chief Executive Officer
	 
	c/o Hines Real Estate Investment Trust, Inc.
2800 Post Oak Boulevard, Suite 5000
Houston, Texas 77056-6118

	 
	 
	 
	 
	 

	Ryan T. Sims
	 
	Chief Financial Officer and Secretary
	 
	c/o Hines Real Estate Investment Trust, Inc.
2800 Post Oak Boulevard, Suite 5000
Houston, Texas 77056-6118

	 
	 
	 
	 
	 

	Kevin L. McMeans
	 
	Asset Management Officer
	 
	c/o Hines Real Estate Investment Trust, Inc.
2800 Post Oak Boulevard, Suite 5000
Houston, Texas 77056-6118

	 
	 
	 
	 
	 

	J. Shea Morgenroth
	 
	Chief Accounting Officer and Treasurer
	 
	c/o Hines Real Estate Investment Trust, Inc.
2800 Post Oak Boulevard, Suite 5000
Houston, Texas 77056-6118

	 
	 
	 
	 
	 

	Jason P. Maxwell
	 
	Assistant Secretary
	 
	c/o Hines Real Estate Investment Trust, Inc.
2800 Post Oak Boulevard, Suite 5000
Houston, Texas 77056-6118

        
FIFTH:  The dissolution of the Corporation has been approved in the manner and by the vote required by law and the charter of the Corporation, as follows:

a)    The Board of Directors of the Corporation, at a duly held meeting, adopted a resolution declaring that the dissolution of the Corporation was advisable and directing that the proposed dissolution be submitted for consideration by the stockholders of the Corporation.
b)    The stockholders of the Corporation, at a duly held meeting, approved the dissolution of the Corporation as so proposed by the Board of Directors of the Corporation.
SIXTH:  The Corporation has no known creditors.
SEVENTH:  The Corporation is hereby dissolved.
EIGHTH:  The undersigned acknowledges these Articles of Dissolution to be the corporate act of the Corporation and as to all matters or facts required to be verified under oath, the undersigned acknowledges that to the best of his knowledge, information and belief, these matters and facts are true in all material respects and that this statement is made under the penalties for perjury.

2

IN WITNESS WHEREOF, the Corporation has caused these Articles of Dissolution to be signed in its name and on its behalf by its President and Chief Executive Officer and attested by its Chief Accounting Officer and Treasurer on this 7th day of March, 2017.
	
			
	ATTEST:
	 
	HINES REAL ESTATE INVESTMENT TRUST, INC.

	 
	 
	 

	/s/ J. Shea Morgenroth
	By:
	/s/ Sherri W. Schugart

	Name: J. Shea Morgenroth
	 
	Name: Sherri W. Schugart

	Title: Chief Accounting Officer and Treasurer
	 
	Title: President and Chief Executive Officer

 
                                   

3hgbl-ex1029_235.htm

 

Exhibit 10.29

 

	
Heritage Global Inc.

2016 Stock Option Plan

Stock Option Award

 

	
 

Name:

 

Address:
	
 

 

 

Heritage Global, Inc.

[Address]

[City, State ZIP]

 

 
	
 
	
 

Grant:  Option to purchase ________ shares of Common Stock

 

             Incentive Stock Option

             Non-Qualified Stock Option

 

Exercise Price: $                         per share

 

Date of Grant:                                       

 

Dear ______________:

Pursuant to Heritage Global Inc.’s (the “Company’s”) 2016 Stock Option Plan (the “Plan”), the Board has now granted to you an option to purchase ___________ shares of the common stock of the Company.  The terms and conditions of this option are as follows:

	
1.
	
The Exercise Price:  The Exercise Price for the shares shall be the amount set forth above, which is at least equal to the closing price on ______________, ____________ ____, 201_ (the “Date of Grant”).

	
2.
	
Vesting:  So long as this option has not expired pursuant to Paragraph 3 hereof, this option will become vested and exercisable in four (4) equal annual installments on each of the first four (4) anniversaries of the Date of Grant.

	
3.
	
Expiration:  Subject to earlier termination pursuant to Paragraph 4 or as otherwise provided in the Plan, the option granted hereby shall expire (become non-exercisable) on ___________ ____, 201_ (the “Expiration Date”) which is ten (10) years after the Date of Grant.

	
4.
	
Change of Status:  Except as otherwise provided herein or in Sections 6.3.3 (relating to permanent and total disability), 6.3.4 (relating to death), and 6.3.5 (relating to “cause”) of the Plan, if your full time employment terminates before the Expiration Date for any reason, the non-vested portion of this option and all rights granted thereby shall immediately terminate, provided, however, except as provided in Paragraph 5, this option may be exercised by you, to the extent otherwise then exercisable, for a period of three (3) months from the date of your termination of employment or until the expiration of the stated term of this option, whichever period is shorter.

	
5.
	
Termination for Cause.  In the event you are terminated from employment with the Company for “cause,” your right to exercise this option, whether vested or non-vested, shall immediately terminate upon notice of discharge.

	
6.
	
Nontransferable:  If the option is designated as an Incentive Stock Option above, the option cannot be transferred except by will or by the laws of descent and distribution.  If the option is designated as a Non-Qualified Stock Option above, the option granted hereunder is may also be transferable to members of the your immediate family (or to one or more trusts for the benefit of such family members or to partnerships or limited liability companies in which such family members or trusts are the only partners or members).

 

 

	
7.
	
Exercise:  To the extent vested pursuant to the terms of this Award Agreement, the option granted herein may be exercised in whole or in part by written notice during the period prior to the Expiration Date.  The notice shall state the number of shares in respect to which the option is being exercised and shall be accompanied by the payment of the full option price as set forth in Section 6.4 of the Plan. Any exercise must be for whole shares only.

	
8.
	
Incentive Stock Option Qualification:  If the option is designated as an Incentive Stock Option above, then this option is granted pursuant to Section 6.1 of the Plan and is intended to qualify as an “incentive stock option” within the meaning of section 422 of the Code, and shall be so construed; provided, however, that nothing in the Plan or this award letter shall be interpreted as a representation, guarantee or other undertaking on the part of the Company that this option is or will be determined to be an incentive stock option.  However, if any portion of this option is deemed not be an incentive stock option because the $100,000 annual limit under section 422(d) of the Code on incentive stock options is exceeded, or otherwise, the portion of this option which cannot be treated as an incentive stock option shall be deemed to be a nonqualified stock option.  In such an event, you will be subject to the tax withholding provisions of Section 6.2.3 of the Plan for the portion of this option which is not an incentive stock option, and all other Plan provisions that apply to nonqualified stock options.

	
9.
	
Notice of Disqualifying Disposition:  If the option is designated as an Incentive Stock Option above, except to the extent that a portion of this option is treated as a nonqualified stock option pursuant to Paragraph 7, above, you must notify the Company of your intent to dispose of any of the shares of common stock of the Company purchased pursuant to this option within two years from the Date of Grant of this option and one year from the date of exercise of this option, and promptly after such disposition you must notify the Company of the number of shares of stock disposed of, the dates of acquisition and disposition of such shares, and the consideration, if any, received on such disposition.  If in connection with any such disposition, the Company becomes liable for withholding taxes and has no amounts owing you with which to discharge its withholding obligation, you shall indemnify the Company against any such taxes and any penalties it may incur through its inability to apply amounts owing you in discharge of it withholding obligation.  Nothing in this Paragraph shall give you any right to dispose of shares of stock in a manner that is inconsistent with any provision of this award letter or the Plan.

	
10.
	
Acceptance:  Your acceptance of this option grant binds you and your legal representatives to all terms and conditions of the Plan, and reference is hereby made to the Plan itself which you may obtain upon written request to the Office of General Counsel of Heritage Global Inc.  In the event of any conflict between the terms of the Plan and the terms of this Agreement, the terms of the Plan shall control. You are advised to consult the Plan for any further information.  Please indicate your acceptance of this option grant by your signature on the copy of this letter and return to me.

Sincerely,

HERITAGE GLOBAL INC.

[Name]

[Title]

ACCEPTED BY:

___________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}]]